 NEW YORK--BUSINESS WIRE--Bragar Eagel Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Talis Biomedical Corporation Talis or the Company NASDAQ: TLIS on behalf of Talis stockholders. Our investigation concerns whether Talis has violated the federal securities laws andor engaged in other unlawful business practices. Click here to participate in the action. On August 10, 2021, Talis reported its second quarter 2021 finan 